EGFR and neoplasm: Signaling pathway activation and tumor cell survival: hepatocyte growth factor (HGF) secreted by CAFs activates the c-Met receptor and restores PI3K/Akt and MAPK/ERK signaling, leading to epidermal growth factor (EGFR)-tyrosine kinase inhibitor (TKI) resistance (33).